| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |